120 related articles for article (PubMed ID: 16010411)
1. Coexpression, prognostic significance and predictive value of EGFR, EGFRvIII and phosphorylated EGFR in colorectal cancer.
Cunningham MP; Essapen S; Thomas H; Green M; Lovell DP; Topham C; Marks C; Modjtahedi H
Int J Oncol; 2005 Aug; 27(2):317-25. PubMed ID: 16010411
[TBL] [Abstract][Full Text] [Related]
2. Coexpression of the IGF-IR, EGFR and HER-2 is common in colorectal cancer patients.
Cunningham MP; Essapen S; Thomas H; Green M; Lovell DP; Topham C; Marks C; Modjtahedi H
Int J Oncol; 2006 Feb; 28(2):329-35. PubMed ID: 16391786
[TBL] [Abstract][Full Text] [Related]
3. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.
Theodoropoulos GE; Karafoka E; Papailiou JG; Stamopoulos P; Zambirinis CP; Bramis K; Panoussopoulos SG; Leandros E; Bramis J
Anticancer Res; 2009 Feb; 29(2):785-91. PubMed ID: 19331236
[TBL] [Abstract][Full Text] [Related]
4. The expression and prognostic significance of HER-2 in colorectal cancer and its relationship with clinicopathological parameters.
Essapen S; Thomas H; Green M; De Vries C; Cook MG; Marks C; Topham C; Modjtahedi H
Int J Oncol; 2004 Feb; 24(2):241-8. PubMed ID: 14719098
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme.
Shinojima N; Tada K; Shiraishi S; Kamiryo T; Kochi M; Nakamura H; Makino K; Saya H; Hirano H; Kuratsu J; Oka K; Ishimaru Y; Ushio Y
Cancer Res; 2003 Oct; 63(20):6962-70. PubMed ID: 14583498
[TBL] [Abstract][Full Text] [Related]
6. Prognostic effect of epidermal growth factor receptor and EGFRvIII in glioblastoma multiforme patients.
Heimberger AB; Hlatky R; Suki D; Yang D; Weinberg J; Gilbert M; Sawaya R; Aldape K
Clin Cancer Res; 2005 Feb; 11(4):1462-6. PubMed ID: 15746047
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor (EGFR) status in primary colorectal tumors does not correlate with EGFR expression in related metastatic sites: implications for treatment with EGFR-targeted monoclonal antibodies.
Scartozzi M; Bearzi I; Berardi R; Mandolesi A; Fabris G; Cascinu S
J Clin Oncol; 2004 Dec; 22(23):4772-8. PubMed ID: 15570078
[TBL] [Abstract][Full Text] [Related]
8. Nuclear expression of phosphorylated EGFR is associated with poor prognosis of patients with esophageal squamous cell carcinoma.
Hoshino M; Fukui H; Ono Y; Sekikawa A; Ichikawa K; Tomita S; Imai Y; Imura J; Hiraishi H; Fujimori T
Pathobiology; 2007; 74(1):15-21. PubMed ID: 17496429
[TBL] [Abstract][Full Text] [Related]
9. Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis.
Psyrri A; Yu Z; Weinberger PM; Sasaki C; Haffty B; Camp R; Rimm D; Burtness BA
Clin Cancer Res; 2005 Aug; 11(16):5856-62. PubMed ID: 16115926
[TBL] [Abstract][Full Text] [Related]
10. Expression of epidermal growth factor receptor (EGFR) and activated EGFR predict poor response to (chemo)radiation and survival in cervical cancer.
Noordhuis MG; Eijsink JJ; Ten Hoor KA; Roossink F; Hollema H; Arts HJ; Pras E; Maduro JH; Reyners AK; de Bock GH; Wisman GB; Schuuring E; van der Zee AG
Clin Cancer Res; 2009 Dec; 15(23):7389-97. PubMed ID: 19920104
[TBL] [Abstract][Full Text] [Related]
11. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor.
Deng Y; Kurland BF; Wang J; Bi J; Li W; Rao S; Lan P; Lin T; Lin E
Am J Clin Oncol; 2009 Jun; 32(3):245-52. PubMed ID: 19451802
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.
Hama T; Yuza Y; Saito Y; O-uchi J; Kondo S; Okabe M; Yamada H; Kato T; Moriyama H; Kurihara S; Urashima M
Oncologist; 2009 Sep; 14(9):900-8. PubMed ID: 19726454
[TBL] [Abstract][Full Text] [Related]
13. Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting.
Sok JC; Coppelli FM; Thomas SM; Lango MN; Xi S; Hunt JL; Freilino ML; Graner MW; Wikstrand CJ; Bigner DD; Gooding WE; Furnari FB; Grandis JR
Clin Cancer Res; 2006 Sep; 12(17):5064-73. PubMed ID: 16951222
[TBL] [Abstract][Full Text] [Related]
14. High predictive value of epidermal growth factor receptor phosphorylation but not of EGFRvIII mutation in resected stage I non-small cell lung cancer (NSCLC).
Sonnweber B; Dlaska M; Skvortsov S; Dirnhofer S; Schmid T; Hilbe W
J Clin Pathol; 2006 Mar; 59(3):255-9. PubMed ID: 16505275
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of epidermal growth factor receptor expression in colon cancer patients undergoing curative surgery.
Galizia G; Lieto E; Ferraraccio F; De Vita F; Castellano P; Orditura M; Imperatore V; La Mura A; La Manna G; Pinto M; Catalano G; Pignatelli C; Ciardiello F
Ann Surg Oncol; 2006 Jun; 13(6):823-35. PubMed ID: 16614884
[TBL] [Abstract][Full Text] [Related]
16. Mutations within the kinase domain and truncations of the epidermal growth factor receptor are rare events in bladder cancer: implications for therapy.
Blehm KN; Spiess PE; Bondaruk JE; Dujka ME; Villares GJ; Zhao YJ; Bogler O; Aldape KD; Grossman HB; Adam L; McConkey DJ; Czerniak BA; Dinney CP; Bar-Eli M
Clin Cancer Res; 2006 Aug; 12(15):4671-7. PubMed ID: 16899617
[TBL] [Abstract][Full Text] [Related]
17. Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation.
Muller S; Su L; Tighiouart M; Saba N; Zhang H; Shin DM; Chen Z
Cancer; 2008 Jul; 113(1):97-107. PubMed ID: 18473353
[TBL] [Abstract][Full Text] [Related]
18. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
[TBL] [Abstract][Full Text] [Related]
19. Expression of epidermal growth factor receptor in relation to BRCA1 status, basal-like markers and prognosis in breast cancer.
Arnes JB; Bégin LR; Stefansson I; Brunet JS; Nielsen TO; Foulkes WD; Akslen LA
J Clin Pathol; 2009 Feb; 62(2):139-46. PubMed ID: 18682421
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of EGF receptor expression in early glottic cancer.
Demiral AN; Sarioglu S; Birlik B; Sen M; Kinay M
Auris Nasus Larynx; 2004 Dec; 31(4):417-24. PubMed ID: 15571917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
